Design and Evaluation of an Electronic Override Mechanism for Medication Alerts to Facilitate Communication Between Prescribers and Pharmacists

Alissa L. Russ, Siying Chen, Brittany L. Melton,, Jason J. Saleem, Michael Weiner, Jeffrey R. Spina, Joanne Daggy, Alan J. Zillich

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Computerized medication alerts can often be bypassed by entering an override rationale, but prescribers’ override reasons are frequently ambiguous to pharmacists who review orders. Objective: To develop and evaluate a new override mechanism for adverse reaction and drug-drug interaction alerts. We hypothesized that the new mechanism would improve usability for prescribers and increase the clinical appropriateness of override reasons. Methods: A counterbalanced, crossover study was conducted with 20 prescribers in a simulated prescribing environment. We modified the override mechanism timing, navigation, and text entry. Instead of free-text entry, the new mechanism presented prescribers with a predefined set of override reasons. We assessed usability (learnability, perceived efficiency, and usability errors) and used a priori criteria to evaluate the clinical appropriateness of override reasons entered. Results: Prescribers rated the new mechanism as more efficient (Wilcoxon signed-rank test, P = 0.032). When first using the new design, 5 prescribers had difficulty finding the new mechanism, and 3 interpreted the navigation to mean that the alert could not be overridden. The number of appropriate override reasons significantly increased with the new mechanism compared with the original mechanism (median change of 3.0; interquartile range = 3.0; P < 0.0001). Conclusions: When prescribers were given a menu-based choice for override reasons, clinical appropriateness of these reasons significantly improved. Further enhancements are necessary, but this study is an important first step toward a more standardized menu of override choices. Findings may be used to improve communication through e-prescribing systems between prescribers and pharmacists.

Original languageEnglish
Pages (from-to)761-769
Number of pages9
JournalAnnals of Pharmacotherapy
Volume49
Issue number7
DOIs
StatePublished - Jul 20 2015

Fingerprint

Pharmacists
Communication
Nonparametric Statistics
Drug-Related Side Effects and Adverse Reactions
Drug Interactions
Cross-Over Studies

Keywords

  • adverse drug reactions
  • drug interactions
  • informatics
  • medication errors
  • medication safety

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Design and Evaluation of an Electronic Override Mechanism for Medication Alerts to Facilitate Communication Between Prescribers and Pharmacists. / Russ, Alissa L.; Chen, Siying; Melton, Brittany L.; Saleem, Jason J.; Weiner, Michael; Spina, Jeffrey R.; Daggy, Joanne; Zillich, Alan J.

In: Annals of Pharmacotherapy, Vol. 49, No. 7, 20.07.2015, p. 761-769.

Research output: Contribution to journalArticle

Russ, Alissa L. ; Chen, Siying ; Melton, Brittany L. ; Saleem, Jason J. ; Weiner, Michael ; Spina, Jeffrey R. ; Daggy, Joanne ; Zillich, Alan J. / Design and Evaluation of an Electronic Override Mechanism for Medication Alerts to Facilitate Communication Between Prescribers and Pharmacists. In: Annals of Pharmacotherapy. 2015 ; Vol. 49, No. 7. pp. 761-769.
@article{51989aa57dd04941abaff365096edb2d,
title = "Design and Evaluation of an Electronic Override Mechanism for Medication Alerts to Facilitate Communication Between Prescribers and Pharmacists",
abstract = "Background: Computerized medication alerts can often be bypassed by entering an override rationale, but prescribers’ override reasons are frequently ambiguous to pharmacists who review orders. Objective: To develop and evaluate a new override mechanism for adverse reaction and drug-drug interaction alerts. We hypothesized that the new mechanism would improve usability for prescribers and increase the clinical appropriateness of override reasons. Methods: A counterbalanced, crossover study was conducted with 20 prescribers in a simulated prescribing environment. We modified the override mechanism timing, navigation, and text entry. Instead of free-text entry, the new mechanism presented prescribers with a predefined set of override reasons. We assessed usability (learnability, perceived efficiency, and usability errors) and used a priori criteria to evaluate the clinical appropriateness of override reasons entered. Results: Prescribers rated the new mechanism as more efficient (Wilcoxon signed-rank test, P = 0.032). When first using the new design, 5 prescribers had difficulty finding the new mechanism, and 3 interpreted the navigation to mean that the alert could not be overridden. The number of appropriate override reasons significantly increased with the new mechanism compared with the original mechanism (median change of 3.0; interquartile range = 3.0; P < 0.0001). Conclusions: When prescribers were given a menu-based choice for override reasons, clinical appropriateness of these reasons significantly improved. Further enhancements are necessary, but this study is an important first step toward a more standardized menu of override choices. Findings may be used to improve communication through e-prescribing systems between prescribers and pharmacists.",
keywords = "adverse drug reactions, drug interactions, informatics, medication errors, medication safety",
author = "Russ, {Alissa L.} and Siying Chen and Melton,, {Brittany L.} and Saleem, {Jason J.} and Michael Weiner and Spina, {Jeffrey R.} and Joanne Daggy and Zillich, {Alan J.}",
year = "2015",
month = "7",
day = "20",
doi = "10.1177/1060028015581678",
language = "English",
volume = "49",
pages = "761--769",
journal = "Annals of Pharmacotherapy",
issn = "1060-0280",
publisher = "Harvey Whitney Books Company",
number = "7",

}

TY - JOUR

T1 - Design and Evaluation of an Electronic Override Mechanism for Medication Alerts to Facilitate Communication Between Prescribers and Pharmacists

AU - Russ, Alissa L.

AU - Chen, Siying

AU - Melton,, Brittany L.

AU - Saleem, Jason J.

AU - Weiner, Michael

AU - Spina, Jeffrey R.

AU - Daggy, Joanne

AU - Zillich, Alan J.

PY - 2015/7/20

Y1 - 2015/7/20

N2 - Background: Computerized medication alerts can often be bypassed by entering an override rationale, but prescribers’ override reasons are frequently ambiguous to pharmacists who review orders. Objective: To develop and evaluate a new override mechanism for adverse reaction and drug-drug interaction alerts. We hypothesized that the new mechanism would improve usability for prescribers and increase the clinical appropriateness of override reasons. Methods: A counterbalanced, crossover study was conducted with 20 prescribers in a simulated prescribing environment. We modified the override mechanism timing, navigation, and text entry. Instead of free-text entry, the new mechanism presented prescribers with a predefined set of override reasons. We assessed usability (learnability, perceived efficiency, and usability errors) and used a priori criteria to evaluate the clinical appropriateness of override reasons entered. Results: Prescribers rated the new mechanism as more efficient (Wilcoxon signed-rank test, P = 0.032). When first using the new design, 5 prescribers had difficulty finding the new mechanism, and 3 interpreted the navigation to mean that the alert could not be overridden. The number of appropriate override reasons significantly increased with the new mechanism compared with the original mechanism (median change of 3.0; interquartile range = 3.0; P < 0.0001). Conclusions: When prescribers were given a menu-based choice for override reasons, clinical appropriateness of these reasons significantly improved. Further enhancements are necessary, but this study is an important first step toward a more standardized menu of override choices. Findings may be used to improve communication through e-prescribing systems between prescribers and pharmacists.

AB - Background: Computerized medication alerts can often be bypassed by entering an override rationale, but prescribers’ override reasons are frequently ambiguous to pharmacists who review orders. Objective: To develop and evaluate a new override mechanism for adverse reaction and drug-drug interaction alerts. We hypothesized that the new mechanism would improve usability for prescribers and increase the clinical appropriateness of override reasons. Methods: A counterbalanced, crossover study was conducted with 20 prescribers in a simulated prescribing environment. We modified the override mechanism timing, navigation, and text entry. Instead of free-text entry, the new mechanism presented prescribers with a predefined set of override reasons. We assessed usability (learnability, perceived efficiency, and usability errors) and used a priori criteria to evaluate the clinical appropriateness of override reasons entered. Results: Prescribers rated the new mechanism as more efficient (Wilcoxon signed-rank test, P = 0.032). When first using the new design, 5 prescribers had difficulty finding the new mechanism, and 3 interpreted the navigation to mean that the alert could not be overridden. The number of appropriate override reasons significantly increased with the new mechanism compared with the original mechanism (median change of 3.0; interquartile range = 3.0; P < 0.0001). Conclusions: When prescribers were given a menu-based choice for override reasons, clinical appropriateness of these reasons significantly improved. Further enhancements are necessary, but this study is an important first step toward a more standardized menu of override choices. Findings may be used to improve communication through e-prescribing systems between prescribers and pharmacists.

KW - adverse drug reactions

KW - drug interactions

KW - informatics

KW - medication errors

KW - medication safety

UR - http://www.scopus.com/inward/record.url?scp=84931026896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931026896&partnerID=8YFLogxK

U2 - 10.1177/1060028015581678

DO - 10.1177/1060028015581678

M3 - Article

VL - 49

SP - 761

EP - 769

JO - Annals of Pharmacotherapy

JF - Annals of Pharmacotherapy

SN - 1060-0280

IS - 7

ER -